Related Experiment Video
Updated: Sep 17, 2025

A Tuberculosis Molecular Bacterial Load Assay TB-MBLA
Published on: April 30, 2020
Tuberculosis treatment adherence and associated factors in the Butha-Buthe district, Lesotho: a retrospective cohort
Motlatsi Rangoanana1, Veranyuy Ngah1, Jacques Lukenze Tamuzi1
1Division of Epidemiology and Biostatistics, Department of Global Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
Introduction:
Lesotho remains one of the world's 30 high-tuberculosis (TB) burden countries. In Butha-Buthe district, unfavourable TB treatment outcomes were higher than those set forth by the WHO. This study's objective was to evaluate TB treatment adherence and treatment resistance among patients enrolled in the 12 health facilities in Butha-Buthe.
Methods:
data were collected from the medical records of patients with sputum smear-positive TB and extra-pulmonary forms of TB between January 2015 and December 2020. Results were presented in frequencies and percentages. Univariate and multivariable logistic regression analyses were conducted to identify factors associated with treatment adherence.
Results:
among 1,792 patients who were enrolled, 1,320 were included in the study. The overall mean TB treatment adherence rate was estimated at 37.20%. Factors found to be associated with treatment adherence in multivariate analysis were age ≥60 years (aOR: 0.59, 95%CI: 0.54- 0.66; P<0.001), being a mine worker (aOR 1.09, 95%CI: 1.03-1.14; P<0.001), having pulmonary TB (aOR: 1.23, 95%CI: 1.17-1.29, P<0.001), being in the continuation phase of the treatment (aOR 1.38, 95%CI: 1.33, 1.45; P<0.001) and category 2 (aOR 0.93, 95%CI: 0.88-0.99; P = 0.016). Regarding TB contact support, family members (aOR: 1.08, 95%CI: 1.03-1.14; P<0.001), friends (aOR 1.30, 95%CI: 1.19-1.41; P<0.001), spouses (aOR: 1.24, 95%CI 1.16-1.34; P<0.001), and unreported contacts (aOR 1.18, 95%CI: 1.09-1.27; P = 0.015) all showed increased TB adherence.
Conclusion:
the overall adherence to TB therapy was poor in Butha-Buthe district. Lesotho urgently needs district-level strategies to improve TB treatment adherence and reduce treatment resistance.
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Other Pulmonary Disorders

